NovoCure Investor Relations Material
Latest events
Q4 2023
NovoCure
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from NovoCure Limited
Access all reports
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. It provides Tumor Treating Fields (TTFields), which are characterized by low-intensity, high-frequency oscillating electric fields that disrupt cell division. The company offers TTFields delivery systems to deliver low intensity alternating electric fields in combination with standard of care chemotherapy.
Key slides for NovoCure Limited
Study Update
NovoCure Limited
Q4 2023
NovoCure Limited
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States